FORM NEWS why is Formfactor, Inc. price falling or rising

FORM NEWS reasons for why stock price of Formfactor, Inc. is falling or rising

FORM Formfactor Inc is falling or rising technical reasons

Technical analysis forecast for Formfactor Inc Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Formfactor Inc FORM at this time. Stock is falling and might fall more.

It appears as if Formfactor Inc FORM gave a large move recently.

Stock of Formfactor Inc (FORM) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Formfactor Inc is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 25.4 as stoploss in an intra day buy trade for a target of 26.73. However, stock will show a bearish move below 25.4.

FORM Formfactor Inc is falling or rising NEWS fundamental reasons

India's 5-year bond to outperform 10-year peer on policy easing: StanChart's Kulkarni India's five-year government bond is set to outperform the 10-year benchmark bond in the coming months as short-term debt will get a boost from further monetary policy easing, a rates strategist with Standard Chartered Bank said on Wednesday. - NEWS as on 2025-04-16 indiatimes.com

Assam govt plans to transform GMCH into one of India's largest hospitals Assam Chief Minister Himanta Biswa Sarma is undertaking steps to transform Gauhati Medical College and Hospital into one of India's largest. The upcoming Mother and Child Care Hospital on GMCH premises will offer specialized pediatric care with 800 beds. - NEWS as on 2025-04-16 indiatimes.com

Kraig Labs Unveils Next-Gen Gene-Splicing Platform To Advance Spider Silk Development (RTTNews) - Kraig Biocraft Laboratories, Inc. (KBLB), Tuesday announced that it has successfully launched a next-generation gene-splicing and molecular biology platform. - NEWS as on 2025-04-15 nasdaq.com

USFDA issues Form 483 with 11 observations to Raleigh plant of Aurobindo Pharma arm Aurobindo Pharma Ltd announced that the USFDA issued a Form 483 with 11 observations following an inspection of its Aurolife Pharma LLC's Raleigh plant in North Carolina. The company stated that the observations are procedural and it will respond with corr - NEWS as on 2025-04-11 indiatimes.com

Flexicap funds may outperform as market stability shifts strategy : Samir Shah, Axis Securities Flexicap funds, currently focused on largecaps due to market volatility, may shift towards mid- and smallcaps once stability returns, offering higher return potential than constrained multi-asset or multi-cap funds with fixed allocation criteria, says Sami - NEWS as on 2025-04-10 indiatimes.com

IIT-Madras, Ziroh Labs Launch CPU-Based AI Platform to Bridge India’s Compute Divide IIT-Madras and its technology arm, IITM Pravartak Technologies Foundation, have partnered with California-based deep-tech startup Ziroh Labs to launch a Centre of AI Research. The centre will focus on developing smaller, task-specific AI models that can be - NEWS as on 2025-04-09 indiatimes.com

BPCL, Sembcorp form JV to boost green hydrogen transition and renewable energy in India Sembcorp Green Hydrogen India and Bharat Petroleum Corporation Ltd (BPCL) have formed a 50:50 joint venture to develop renewable energy and green hydrogen projects across India. The partnership will focus on producing and selling green hydrogen, its deriva - NEWS as on 2025-04-08 indiatimes.com

Sebi joins social media platform 'X'. Check ID and other details Sebi has launched its official account on social media platform 'X' under @SEBI_updates. It aims to improve investor awareness while clarifying that posts are for information, not regulation. Sebi also unveiled an investor charter promoting rights and resp - NEWS as on 2025-04-04 indiatimes.com

More announcements and NEWS

FORM Formfactor, Inc. current price & indicator signals